Pricing
ImmunoVec
Contact
No bio yet
William Woodward
Co-Founder and CEO
Doug Sills
Vice President Of Corporate Development & Co-founder
Dillon Woodward
Director Of People, Marketing & Strategic Partnerships; Co-founder
This person is not in any teams
This person is not in any offices
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system. Its gene therapy is intended for hematopoietic diseases.
Industries
Headquarters
Employees
Links
LiquidOps
Bantee
DolarApp
Monoova
Hireframe
View more